RT Book, Section
A1 Isaacs, Claudine
A1 Wellstein, Anton
A1 Riegel, Anna T.
A2 Brunton, Laurence L.
A2 Hilal-Dandan, Randa
A2 Knollmann, Björn C.
SR Print(0)
ID 1162547611
T1 Hormones and Related Agents in the Therapy of Cancer
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259584732
LK accesspharmacy.mhmedical.com/content.aspx?aid=1162547611
RD 2024/04/19
AB A  Note  on  Treatment  RegimensCancer  treatment  regimens  change  to  reflect  continuous  advances  in  basic  and  clinical  science:  new  drugs,  both  small  molecules  and  biologicals;  improved  methods  of  targeting  and  timing  of  drug  delivery;  agents  with  altered  pharmacokinetic  properties  and  selectivities;  the  use  of  rational  multidrug  combinations;  and  greater  knowledge  of  the  basic  cell  biology  of  tumorigenesis,  metastasis,  and  immune  function,  amongst  other  advances.  As  a  consequence,  this  chapter  presents  relatively  few  detailed  treatment  regimens;  rather,  we  refer  the  reader  to  the  web-based  resources  of  the  U.S.  FDA  and  the  NCCN.  Table  67–1  provides  the  details  and  demonstrates  the  complexities  of  treatment  of  two  cancers.